Australia markets open in 4 hours 35 minutes

Fresenius Medical Care AG (FMED.XC)

Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
38.03+0.47 (+1.24%)
At close: 10:21AM BST
Full screen
Previous close37.57
Open38.03
Bid38.47 x N/A
Ask35.93 x N/A
Day's range38.03 - 38.03
52-week range30.28 - 39.72
Volume289
Avg. volume84
Market cap11.398B
Beta (5Y monthly)0.86
PE ratio (TTM)21.01
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield1.19 (3.17%)
Ex-dividend date17 May 2024
1y target estN/A
  • PR Newswire

    Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software

    Fresenius Medical Care (FME), a global leader in kidney care, has achieved a growth milestone of more than 14,000 U.S.-based patients using the Company's NxStage systems to perform Home Hemodialysis (HHD) therapy through both Fresenius Kidney Care clinics and other providers. The company has in parallel launched the newest version of its home dialysis machine, the NxStage® Versi®HD with GuideMe Software, featuring enhancements designed to simplify treatment, increase ease of learning, and improv

  • PR Newswire

    Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024

    "In the second quarter, we further improved our financial performance while executing against our strategic plan and the company transformation. This quarter is another important proof point for the operational turnaround as we remain focused to deliver on our targets", said Helen Giza, Chief Executive Officer of Fresenius Medical Care AG. "Our operating income margin progressed toward our 2025 margin target band, as Care Enablement increased its profitability. In Care Delivery, U.S. same market

  • PR Newswire

    Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations

    Fresenius Medical Care (FME), the world's leading provider of products and services for people with kidney disease, has signed five virtual power purchase agreements (vPPAs) with wind and solar energy project developers in Germany and the U.S. The projects are expected to feed around 580 gigawatt hours of renewable energy into the grid, which equals up to 46 percent of FME's most recently reported global consumption. The company is thus taking an important step towards its goal of reducing emiss